Candidates preparing for the GATE 2027 Data Science and Artificial Intelligence (DA) paper can use the previous three ...

AI-generated Recursion Pharmaceuticals (RXRX) stock analysis report, as of Nov 3, 2026. See RXRX business overview, financial statement overview, technical analysis and price target.

Artificial Intelligence in Drug Discovery Market growth is driven by R&D investment, generative AI, and pharma partnerships.

Google’s own AI leadership is now talking openly about self-improving models, and the company has launched Gemini 4 Argon, rolling it out globally to AI Pro and Ultra subscribers in October 2026. That ...

German returns to what he does best: injecting nihilism and savagery into clubs” – Les InRocks Choosing 7LLVSION’s tracklist, ...

Engineered algorithms identify strongly unique genomic k-mers in seconds across billions of sequences, substantially accelerating alignment-free sequence analysis and xenograft sorting.

Anthropic's amended S-1 warns investors the company may "imminently" hit its own threshold for dramatically accelerated AI progress — and hosts of ...

Control pulses restore qubit behavior in multi-level systems using an iterative quantum Kolmogorov-Arnold-Moser algorithm.

An independent evaluation by METR found Anthropic's internal AI progress roughly doubled over the past year — matching two years of gains in twelve ...